Affimed N.V. (PNK: AFMDQ) Stock Competitors & Peer Comparison

Affimed N.V. (PNK: AFMDQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SGMO has a market cap of 30.7M. Regarding current trading prices, AFMDQ is priced at $0.00 on the PNK, while SGMO trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFMDQ currently has a P/E ratio of N/A, whereas SGMO's P/E ratio is -0.20. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SGMO's ROE of +66.86%. Regarding short-term risk, AFMDQ is less volatile compared to SGMO. This indicates lower risk in terms of short-term price fluctuations for AFMDQ.Check SGMO's competition here

Affimed N.V. (PNK: AFMDQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ADTX has a market cap of 3.7M. Regarding current trading prices, AFMDQ is priced at $0.00 on the PNK, while ADTX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFMDQ currently has a P/E ratio of N/A, whereas ADTX's P/E ratio is N/A. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ADTX's ROE of +9.26%. Regarding short-term risk, AFMDQ is less volatile compared to ADTX. This indicates lower risk in terms of short-term price fluctuations for AFMDQ.Check ADTX's competition here

Affimed N.V. (PNK: AFMDQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ITRMF has a market cap of 2.7M. Regarding current trading prices, AFMDQ is priced at $0.00 on the PNK, while ITRMF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFMDQ currently has a P/E ratio of N/A, whereas ITRMF's P/E ratio is -0.07. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ITRMF's ROE of +4.42%. Regarding short-term risk, AFMDQ is less volatile compared to ITRMF. This indicates lower risk in terms of short-term price fluctuations for AFMDQ.Check ITRMF's competition here

Affimed N.V. (PNK: AFMDQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, CASIF has a market cap of 2.6M. Regarding current trading prices, AFMDQ is priced at $0.00 on the PNK, while CASIF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFMDQ currently has a P/E ratio of N/A, whereas CASIF's P/E ratio is -0.05. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CASIF's ROE of +2.04%. Regarding short-term risk, AFMDQ is similarly volatile compared to CASIF. This indicates similar risk in terms of short-term price fluctuations for AFMDQ.Check CASIF's competition here

Affimed N.V. (PNK: AFMDQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, OCEA has a market cap of 237.3K. Regarding current trading prices, AFMDQ is priced at $0.00 on the PNK, while OCEA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFMDQ currently has a P/E ratio of N/A, whereas OCEA's P/E ratio is N/A. In terms of profitability, AFMDQ's ROE is -1.01%, compared to OCEA's ROE of +0.04%. Regarding short-term risk, AFMDQ is less volatile compared to OCEA. This indicates lower risk in terms of short-term price fluctuations for AFMDQ.Check OCEA's competition here

Affimed N.V. (PNK: AFMDQ) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BIORQ has a market cap of 905. Regarding current trading prices, AFMDQ is priced at $0.00 on the PNK, while BIORQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFMDQ currently has a P/E ratio of N/A, whereas BIORQ's P/E ratio is N/A. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BIORQ's ROE of +1.22%. Regarding short-term risk, AFMDQ is similarly volatile compared to BIORQ. This indicates similar risk in terms of short-term price fluctuations for AFMDQ.Check BIORQ's competition here